Prognostic value of CXLC 9 in patients undergoing neoadjuvant radiochemotherapy and surgery in stage IIIA NSCLC.

Wolfgang Parsch; RM Wirtz; Bettina Braunecker; D Wurflein; Clemens Albrecht; D Kraus; Thomas  Papadopoulos; Joachim H. Ficker; WM Brueckl

doi:10.1200/JCO.2018.36.15_suppl.e24156

Prognostic value of CXLC 9 in patients undergoing neoadjuvant radiochemotherapy and surgery in stage IIIA NSCLC.

Wolfgang Parsch
, RM Wirtz
, Bettina Braunecker
, D Wurflein
, Clemens Albrecht
, D Kraus
, Thomas Papadopoulos
, Joachim H. Ficker
, WM Brueckl

Research output: Contribution to journal › Abstract (Journal) › peer-review

Original language	English
Journal	JOURNAL OF CLINICAL ONCOLOGY
Volume	36
Issue number	15
DOIs	https://doi.org/10.1200/JCO.2018.36.15_suppl.e24156
Publication status	Published - 2018

Access to Document

10.1200/JCO.2018.36.15_suppl.e24156

Cite this

Parsch, W., Wirtz, RM., Braunecker, B., Wurflein, D., Albrecht, C., Kraus, D., Papadopoulos, T., Ficker, J. H., & Brueckl, WM. (2018). Prognostic value of CXLC 9 in patients undergoing neoadjuvant radiochemotherapy and surgery in stage IIIA NSCLC. JOURNAL OF CLINICAL ONCOLOGY , 36(15). https://doi.org/10.1200/JCO.2018.36.15_suppl.e24156

Parsch, Wolfgang ; Wirtz, RM ; Braunecker, Bettina et al. / Prognostic value of CXLC 9 in patients undergoing neoadjuvant radiochemotherapy and surgery in stage IIIA NSCLC. In: JOURNAL OF CLINICAL ONCOLOGY 2018 ; Vol. 36, No. 15.

@article{62d5c41ff9cf49e28e873a6cfaa99385,

title = "Prognostic value of CXLC 9 in patients undergoing neoadjuvant radiochemotherapy and surgery in stage IIIA NSCLC.",

author = "Wolfgang Parsch and RM Wirtz and Bettina Braunecker and D Wurflein and Clemens Albrecht and D Kraus and Thomas Papadopoulos and Ficker, \{Joachim H.\} and WM Brueckl",

year = "2018",

doi = "10.1200/JCO.2018.36.15\_suppl.e24156",

language = "English",

volume = "36",

journal = "JOURNAL OF CLINICAL ONCOLOGY ",

issn = "0732-183X",

publisher = "Lippincott Williams \& Wilkins ",

number = "15",

}

Parsch, W, Wirtz, RM, Braunecker, B, Wurflein, D, Albrecht, C, Kraus, D, Papadopoulos, T, Ficker, JH & Brueckl, WM 2018, 'Prognostic value of CXLC 9 in patients undergoing neoadjuvant radiochemotherapy and surgery in stage IIIA NSCLC.', JOURNAL OF CLINICAL ONCOLOGY , vol. 36, no. 15. https://doi.org/10.1200/JCO.2018.36.15_suppl.e24156

Prognostic value of CXLC 9 in patients undergoing neoadjuvant radiochemotherapy and surgery in stage IIIA NSCLC. / Parsch, Wolfgang; Wirtz, RM; Braunecker, Bettina et al.
In: JOURNAL OF CLINICAL ONCOLOGY , Vol. 36, No. 15, 2018.

Research output: Contribution to journal › Abstract (Journal) › peer-review

TY - JOUR

T1 - Prognostic value of CXLC 9 in patients undergoing neoadjuvant radiochemotherapy and surgery in stage IIIA NSCLC.

AU - Parsch, Wolfgang

AU - Wirtz, RM

AU - Braunecker, Bettina

AU - Wurflein, D

AU - Albrecht, Clemens

AU - Kraus, D

AU - Papadopoulos, Thomas

AU - Ficker, Joachim H.

AU - Brueckl, WM

PY - 2018

Y1 - 2018

U2 - 10.1200/JCO.2018.36.15_suppl.e24156

DO - 10.1200/JCO.2018.36.15_suppl.e24156

M3 - Abstract (Journal)

SN - 0732-183X

VL - 36

JO - JOURNAL OF CLINICAL ONCOLOGY

JF - JOURNAL OF CLINICAL ONCOLOGY

IS - 15

ER -

Parsch W, Wirtz RM, Braunecker B, Wurflein D, Albrecht C, Kraus D et al. Prognostic value of CXLC 9 in patients undergoing neoadjuvant radiochemotherapy and surgery in stage IIIA NSCLC. JOURNAL OF CLINICAL ONCOLOGY . 2018;36(15). doi: 10.1200/JCO.2018.36.15_suppl.e24156